Tower Research Capital (TRC)’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,225
| Closed | -$4K | – | 6893 |
|
|
2021
Q4 | $4K | Buy |
+1,225
| New | +$4K | ﹤0.01% | 5380 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | – | – | 4661 |
|
|
2019
Q2 | $0 | Sell |
1
-39
| -98% | – | ﹤0.01% | 4500 |
|
|
2019
Q1 | $1K | Sell |
40
-67
| -63% | -$1.68K | ﹤0.01% | 3661 |
|
|
2018
Q4 | $2K | Buy |
+107
| New | +$2K | ﹤0.01% | 3472 |
|
|
2018
Q2 | – | Sell |
-32
| Closed | -$1K | – | 4206 |
|
|
2018
Q1 | $1K | Sell |
32
-116
| -78% | -$3.63K | ﹤0.01% | 3123 |
|
|
2017
Q4 | $6K | Buy |
148
+119
| +410% | +$4.82K | ﹤0.01% | 2839 |
|
|
2017
Q3 | $2K | Buy |
29
+9
| +45% | +$621 | ﹤0.01% | 3607 |
|
|
2017
Q2 | $1K | Sell |
20
-337
| -94% | -$16.9K | ﹤0.01% | 2540 |
|
|
2017
Q1 | $9K | Buy |
357
+10
| +3% | +$252 | ﹤0.01% | 1879 |
|
|
2016
Q4 | $7K | Buy |
347
+29
| +9% | +$585 | ﹤0.01% | 2891 |
|
|
2016
Q3 | $8K | Hold |
318
| – | – | ﹤0.01% | 2250 |
|
|
2016
Q2 | $8K | Hold |
318
| – | – | ﹤0.01% | 3057 |
|
|
2016
Q1 | $14K | Buy |
318
+313
| +6,260% | +$13.8K | ﹤0.01% | 1651 |
|
|
2015
Q4 | $0 | Sell |
5
-57
| -92% | – | ﹤0.01% | 5236 |
|
|
2015
Q3 | $3K | Sell |
62
-721
| -92% | -$34.9K | ﹤0.01% | 3197 |
|
|
2015
Q2 | $41K | Buy |
+783
| New | +$41K | ﹤0.01% | 1534 |
|